These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 7673698)

  • 1. Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression.
    Basiri H; Kiura K; DeNardin EG; Nakamura I
    J Immunol; 1995 Sep; 155(6):2822-32. PubMed ID: 7673698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Ly-49 family: regulation of cytotoxicity and cytokine production in murine CD3+ cells.
    Ortaldo JR; Winkler-Pickett R; Mason AT; Mason LH
    J Immunol; 1998 Feb; 160(3):1158-65. PubMed ID: 9570529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host MHC class I molecules modulate in vivo expression of a NK cell receptor.
    Karlhofer FM; Hunziker R; Reichlin A; Margulies DH; Yokoyama WM
    J Immunol; 1994 Sep; 153(6):2407-16. PubMed ID: 8077656
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NK cell granule exocytosis and cytokine production inhibited by Ly-49A engagement.
    Kim S; Yokoyama WM
    Cell Immunol; 1998 Feb; 183(2):106-12. PubMed ID: 9606994
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of conserved glycosylation site unique to murine class I MHC in recognition by Ly-49 NK cell receptor.
    Lian RH; Freeman JD; Mager DL; Takei F
    J Immunol; 1998 Sep; 161(5):2301-6. PubMed ID: 9725224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of hemopoietic histocompatibility antigens on H-2-loss variants of F1 hybrid lymphoma cells: evidence consistent with trans gene regulation.
    Rembecki RM; Bennett M; Kumar V; Potter TA
    J Immunol; 1987 Apr; 138(8):2734-8. PubMed ID: 3549904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The alpha2 domain of H-2Dd restricts the allelic specificity of the murine NK cell inhibitory receptor Ly-49A.
    Sundbäck J; Nakamura MC; Waldenström M; Niemi EC; Seaman WE; Ryan JC; Kärre K
    J Immunol; 1998 Jun; 160(12):5971-8. PubMed ID: 9637511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of the rejection of bone marrow allografts by the depletion of activating versus inhibiting Ly-49 natural killer cell subsets.
    Raziuddin A; Longo DL; Mason L; Ortaldo JR; Bennett M; Murphy WJ
    J Immunol; 1998 Jan; 160(1):87-94. PubMed ID: 9551959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for sulfate modification of H-2Dd on N-linked carbohydrate(s): possible involvement in Ly-49A interaction.
    Chang CS; Kane KP
    J Immunol; 1998 May; 160(9):4367-74. PubMed ID: 9574541
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The regulatory functions of Ly-49A, Ly-49D and Ly-49G2 on NK cells in the recognition and rejection of the alloantigen in vivo.
    Shimizu I; Tomita Y; Iwai T; Zhang QW; Matsuzaki G; Nomoto K; Yasui H
    Transpl Int; 2005 Sep; 18(9):1090-9. PubMed ID: 16104890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
    George TC; Ortaldo JR; Lemieux S; Kumar V; Bennett M
    J Immunol; 1999 Aug; 163(4):1859-67. PubMed ID: 10438920
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recognition of CHO cells by inhibitory and activating Ly-49 receptors.
    Mason LH
    J Leukoc Biol; 2000 Oct; 68(4):583-6. PubMed ID: 11037982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokine-activated killer (LAK) cells. IV. Characterization of murine LAK effector subpopulations.
    Ballas ZK; Rasmussen W
    J Immunol; 1990 Jan; 144(1):386-95. PubMed ID: 2104892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ability of H-2Dd molecule to affect natural resistance to hemopoietic allografts is an intrinsic property shared by Ddm1 but not Ld.
    Milisauskas VK; Nakamura I
    Eur J Immunol; 1994 Feb; 24(2):336-42. PubMed ID: 8299682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells.
    Karlhofer FM; Ribaudo RK; Yokoyama WM
    Nature; 1992 Jul; 358(6381):66-70. PubMed ID: 1614533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Major histocompatibility complex class I-dependent cell binding to isolated Ly-49A: evidence for high-avidity interaction.
    Chang CS; Shen L; Gong DE; Kane KP
    Eur J Immunol; 1996 Dec; 26(12):3219-23. PubMed ID: 8977325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cutting edge: expression of functional CD94/NKG2A inhibitory receptors on fetal NK1.1+Ly-49- cells: a possible mechanism of tolerance during NK cell development.
    Sivakumar PV; Gunturi A; Salcedo M; Schatzle JD; Lai WC; Kurepa Z; Pitcher L; Seaman MS; Lemonnier FA; Bennett M; Forman J; Kumar V
    J Immunol; 1999 Jun; 162(12):6976-80. PubMed ID: 10358137
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recognition of class I MHC by NK receptor Ly-49C: identification of critical residues.
    Lian RH; Li Y; Kubota S; Mager DL; Takei F
    J Immunol; 1999 Jun; 162(12):7271-6. PubMed ID: 10358175
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ly-49-independent inhibition of natural killer cell-mediated cytotoxicity by a soluble major histocompatibility complex class I molecule.
    Roth C; Kourilsky P; Ojcius DM
    Eur J Immunol; 1994 Sep; 24(9):2110-4. PubMed ID: 8088332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Levels of Ly-49 receptor expression are determined by the frequency of interactions with MHC ligands: evidence against receptor calibration to a "useful" level.
    Manilay JO; Waneck GL; Sykes M
    J Immunol; 1999 Sep; 163(5):2628-33. PubMed ID: 10453002
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.